Press Room
November 2011
Kidney Failure Patients Missing out on Convenient, Cost-Effective Therapy, Study Says
New York, NY (November 28, 2011) — While 382,000 patients in the U.S. receive dialysis treatment for kidney failure, only 35,000 dialyze at home. A special report in the December issue...
November 2011
Toray and Mitsubishi Tanabe Pharma Reach North American License Agreement on Antipruritic Agent TRK-820
Toray and Mitsubishi Tanabe Pharma Reach North American License Agreement on Antipruritic Agent TRK-820
October 2011
New Policy Reduces Racial Disparity in Transplantation
New York, NY (October 26, 2011) — A change in the kidney allocation policy dramatically reduced the racial disparity between the rates at which African Americans and whites receive...
October 2011
National Kidney Foundation Names New CEO
New York, NY (October 24, 2011) — Bruce Skyer, of Trumbull, Connecticut, was named Chief Executive Officer (CEO) of the National Kidney Foundation, the Board of Directors announced...
October 2011
Pre-Dialysis Nutrition Linked to Lower Mortality
New York, NY (October 1, 2011) — Tragically, the first year of dialysis for patients with end-stage renal disease (ESRD) often proves to be the last. However, new data published in the...
August 2011
Do-it-Yourself Questionnaire Can Help Derail Major Illnesses
New York, NY (August 1, 2011) — Sometimes what you can’t see can kill you. Excessive protein in the urine, or albuminuria, almost always goes undetected. Yet, this condition...
August 2011
Durbin, Cochran Introduce Legislation to Help Organ Transplant Patients
Washington, DC (August 1, 2011) — U.S. Senators Dick Durbin (D-IL), Thad Cochran (R-MS), and Scott Brown (R-MA) today introduced bipartisan legislation to improve the quality of life...
June 2011
NKF Statement Regarding FDA Approval of Modified Language on Labels for ESAs
New York, NY (June 27, 2011) - The new label for the use of erythropoiesis-stimulating agents (ESAs), is consistent with the National Kidney Foundation's position that medical decisions...
June 2011
Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
